Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase NA 5Phase 2 5Phase EARLY_PHASE1 3Phase 2/3 3Phase 4 1Phase 1/2 1

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Leukemia 1Carcinoma, Lobular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 524Specimen Handling 383Carboplatin 377Magnetic Resonance Spectroscopy 336Cisplatin 332Nivolumab 308Cyclophosphamide 298Radiotherapy 257Paclitaxel 255Gemcitabine 235Biopsy 235Bevacizumab 218Dexamethasone 169durvalumab 168Oxaliplatin 163Capecitabine 158Rituximab 157Fluorouracil 149venetoclax 147Docetaxel 147Etoposide 142Drug Therapy 142atezolizumab 141Doxorubicin 134Ipilimumab 129Radiosurgery 120Prednisone 120Lenalidomide 119Leucovorin 113fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Positron Emission Tomography Computed Tomography × 1 year × Clear all
NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT01920737 2025-09-16

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
39 enrolled
Other hematologic neoplasm

Leukemia

NCT06055790 2025-09-03

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

University of Arizona

Phase 2 Recruiting
20 enrolled
CNS

Brain Neoplasms

NCT03314636 2025-08-08

CONPET

Oslo University Hospital

Phase 2 Active not recruiting
53 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT03204123 2025-07-09

PSMA PET Imaging of Recurrent Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
1,171 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡